PitchBook is a resource for data, research, and insights spanning the global capital markets. Founded in 2007 and acquired by Morningstar in 2016, PitchBook's data on the private and public markets helps business professionals discover and execute opportunities.
N/A
WellSky CareTend
Score 7.1 out of 10
N/A
CareTend is an integrative healthcare solution that is customized to meet the needs of a dynamic industry. CareTend is used to schedule visits, record patient records, create claims, fill prescriptions, manage inventory, bill, and record.
Appropriate: We will use Pitchbook, for example, when we need to screen for companies in a certain sector or when a keyword gets a priced funding round (Seed, Series A, B, C). Screening of deal as a way to benchmark prices of potential investments Screening of potential LPs based on past investments Challenging: Quickly pull analyst commentary on certian companies/events. consensus sales or prices Analyse non venture deals. for example in biotech, licensing deals are key ways to create value and always analysed in detailed. We will probabaly use dealbook or Cortellis for this
This company is extremely difficult to work with. They have expressed that CareTend users are not important to them since that is such a small part of the WellSky business. They are very focused on extra fees and extra charges for everything. We have not even had the program for a year and they have changed everything initially promised related to pricing. They continue to come up with new ways they can get more money out of you. I would recommend for anyone considering this program, to look at other options first
I am very unsatisfied with WellSky CareTend. The original CPR+ program was efficient and this copy they forced provider to switch to has many issues and does not include all of the capabilities in the prior program or as promised.
The price is insane. Most of their competitors are free, and those that aren't are less than 5% the price of PitchBook.
The excel plugin is incredibly complicated and the formula builder function is awful. You cannot search easily to find formulas for things you don't already know (unless you ask support)
The UI is old, and they are slow to innovate. They need to add in a new incredible feature in the next year or two or my firm might move on, as it's getting harder to justify the price when competitors get better every year (signalnfx!) and PitchBook doesn't.
Poor customer service. Upper Management fired much of the staff soon after our transition.
Outrageous fees that keep changing and increasing multiple times since we transitioned 9/2019. Getting a contract up front proves pointless as they find crafty ways around agreements to charge exorbitant fees. We are always overbilled. Just transitioned and bought a new server and now they tell us they are eliminating that process and we will be forced to host with them at a price of $66k/year for 20 users. This is above and beyond the 5% increase they gave us across the board 3 months after transitioning and the quarterly support fees that are outrageous.
Any attempt to discuss or protest the charges is met with the explanation that WellSky is a very big company and CareTend is such a small component that they are not interested in our concerns.
They do not have any clinical staff consulting or employed and are definitely missing functionality for what is needed in different clinical components or operations of the program.
WellSky bought the CPR+ program that we were using and decided to eliminate all support of that program and forced customers to purchase the CareTend program. They promised we could do everything we could in CPR+ plus much more. That has not been the case. Our staff has spent unbelievable amounts of hours just to try to get some of the basic functions of CPR+. We have adapted many work arounds. CareTend sees fixes to their program issues as enhancements and insists on charging exorbitant fees to add these corrective updates.
I rely on PitchBook when researching potential investments, particularly in the tech and AI space. It’s an excellent tool for early-stage market analysis and becomes especially valuable when evaluating private or emerging startups. PitchBook provides all the essential company details—financials, funding history, valuations—which are critical for my work as an investment professional. The three points I took out is for the lack of market analysis framework and the lack of P&L data.
The overall support for PitchBook is about average. It is not excellent for two primary reasons. First, PitchBook can run slow from time to time, and I cannot copy and paste from the Chrome extension. I have found neither of those issues to be a function of the computer I am using. However, the PitchBook support team has proved helpful on several occasions.
They fired most of the support staff. When your staff is new to the program, yet knows more than who you speak to when you call into support, you know that there is an issue. It can take a week or longer at times for a support person to get back to you about an issue. We have met with management on these issues and when they do acknowledge a functionality issue, they want to charge you a fee to provide the fix even though you already pay support fees
Really well - though I think Beauhurst has the edge on UK specific investments, and Bloomberg has the edge on immediate updates. I think PitchBook is better than fDi Markets though, I would definitely recommend purchasing a PitchBook license over fDi Markets - but in a policy area that isn’t considering international investment, I might go with Beauhurst.
